Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.3%

291 terminated/withdrawn out of 1783 trials

Success Rate

78.5%

-8.1% vs industry average

Late-Stage Pipeline

9%

169 trials in Phase 3/4

Results Transparency

51%

542 of 1062 completed trials have results

Key Signals

210 recruiting542 with results173 terminated118 withdrawn

Enrollment Performance

Analytics

N/A
870(60.0%)
Phase 2
232(16.0%)
Phase 1
129(8.9%)
Phase 4
109(7.5%)
Phase 3
60(4.1%)
Early Phase 1
49(3.4%)
1449Total
N/A(870)
Phase 2(232)
Phase 1(129)
Phase 4(109)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1783)

Showing 20 of 1783 trials
NCT04613206Phase 2Active Not Recruiting

High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients

Role: collaborator

NCT07227974Not ApplicableRecruiting

Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays

Role: lead

NCT04225507Not ApplicableCompleted

Technology-Supported Treatment of Sleep Apnea in Prediabetes

Role: collaborator

NCT06638021Not ApplicableRecruiting

Targeted EHR-based Communication of Diagnostic Uncertainty in the ED

Role: collaborator

NCT07840599Not ApplicableNot Yet Recruiting

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients

Role: lead

NCT07732179Not ApplicableCompleted

Aromatherapy and Music Impact on Nurses' Stress at Work

Role: lead

NCT06230744Not ApplicableRecruiting

A Novel Intervention for Weight Loss in Young Adults

Role: collaborator

NCT06666673Early Phase 1Recruiting

Effect of Neural Constraints on Movement in Stroke

Role: lead

NCT05836987Phase 3Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Role: collaborator

NCT05864534Phase 2Active Not Recruiting

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Role: lead

NCT05873634Recruiting

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

Role: lead

NCT03871075Not ApplicableCompleted

Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease

Role: lead

NCT07845461Not ApplicableRecruiting

Testing Intervention Strategies for Addressing Binge Eating and Food Insecurity

Role: lead

NCT06517186Recruiting

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

Role: lead

NCT06676930Not ApplicableCompleted

Impact of Artificial Intelligence on Trainee Polyp Miss Rates

Role: lead

NCT05407415Not ApplicableEnrolling By Invitation

KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation

Role: lead

NCT04634799Phase 1Terminated

Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

Role: lead

NCT05335252Phase 3Active Not Recruiting

Dronabinol After Arthroscopic Surgery

Role: lead

NCT05038709Not ApplicableActive Not Recruiting

Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness

Role: lead

NCT04228978Not ApplicableActive Not Recruiting

Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

Role: lead